Hyloris Pharmaceuticals SA
XBRU:HYL

Watchlist Manager
Hyloris Pharmaceuticals SA Logo
Hyloris Pharmaceuticals SA
XBRU:HYL
Watchlist
Price: 4.29 EUR -6.94% Market Closed
Market Cap: 120.1m EUR
Have any thoughts about
Hyloris Pharmaceuticals SA?
Write Note

Hyloris Pharmaceuticals SA
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hyloris Pharmaceuticals SA
Cost of Revenue Peer Comparison

Comparables:
UCB
TUB

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Hyloris Pharmaceuticals SA
XBRU:HYL
Cost of Revenue
-€93k
CAGR 3-Years
14%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Ucb SA
XBRU:UCB
Cost of Revenue
-€1.7B
CAGR 3-Years
-8%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Financiere de Tubize SA
XBRU:TUB
Cost of Revenue
-€2m
CAGR 3-Years
-25%
CAGR 5-Years
-6%
CAGR 10-Years
15%

See Also

What is Hyloris Pharmaceuticals SA's Cost of Revenue?
Cost of Revenue
-93k EUR

Based on the financial report for Dec 31, 2023, Hyloris Pharmaceuticals SA's Cost of Revenue amounts to -93k EUR.

What is Hyloris Pharmaceuticals SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-7%

Over the last year, the Cost of Revenue growth was 1%. The average annual Cost of Revenue growth rates for Hyloris Pharmaceuticals SA have been 14% over the past three years , -7% over the past five years .

Back to Top